New Antibody Therapy for Head & Neck Cancer

Plus: RNA Combats Polycystic Kidney Disease

Hi friends 👋🏼,

We’ve got 4 awesome stories for you this week:

New Antibody Therapy for Head & Neck Cancer ^{READER REQUEST}
RNA Combats Polycystic Kidney Disease ^{READER REQUEST}
Myasthenia Gravis’ New Targeted Approach ^{READER REQUEST}
Ikaros and Non-Hodgkin Lymphoma ^{READER REQUEST}

Upgrade to Premium for access to weekly articles and to make custom requests from our team of scientists.

(if you’re already a premium member, ignore this little box)

👤 New Antibody Therapy for Head & Neck Cancer

Head and neck cancer includes cancers of the tonsils, mouth, nose, sinuses, throat, and salivary glands. There are over a dozen approved drugs to treat head and neck cancer. Nevertheless, new medicines are being developed and tested that expand and improve upon traditional treatment modalities. We’ll focus on checkpoint inhibitors here 👇🏼

1/ What are checkpoint inhibitors? Checkpoint inhibitors are fundamental mechanisms part of our immune system that fine-tune and control the body’s immune response. But cancer is clever; many cancers hijack these checkpoints, preventing an immune response to cancer and allowing the tumor cells to proliferate unchecked.

Subscribe to The Cure to read the rest.

Become a paying subscriber of The Cure to get access to this post and other subscriber-only content.

Upgrade

Already a paying subscriber? Sign In

A subscription gets you:

Informative scientific & medical breakdowns delivered to your inbox every Sunday

Unique opportunity to submit your disease of interest and have our scientists conduct thorough research on your behalf

Find enrolling clinical trials and access recently approved medicines

Discounted enrollment in our genetic engineering online course